| Customization: | Available |
|---|---|
| Package: | 10vials/Box |
| Composition: | Cerebroprotein |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product | Dose | Package |
| Cerebroprotein For Injection | 30mg | 10vials/box |
Cerebroprotein for Injection is a neurotrophic medication derived from porcine brain tissue, containing a complex mixture of biologically active peptides and proteins. It is primarily used in the treatment of neurological disorders and conditions affecting the central nervous system (CNS), such as stroke, traumatic brain injury, and neurodegenerative diseases. Cerebroprotein is believed to exert neuroprotective and neuroregenerative effects, promoting neuronal survival, synaptic plasticity, and functional recovery in patients with various neurological conditions.
Stroke: Cerebroprotein is indicated for the treatment of acute ischemic stroke and post-stroke rehabilitation. It may help improve neurological outcomes, functional recovery, and quality of life in stroke patients by promoting neuronal survival and repair in the ischemic brain tissue.
Traumatic Brain Injury: Cerebroprotein is used in the management of traumatic brain injury (TBI) to reduce secondary brain injury and enhance neurological recovery. It may help mitigate the effects of neuroinflammation, oxidative stress, and neuronal damage following TBI, promoting tissue repair and functional recovery.
Neurodegenerative Diseases: Cerebroprotein has been investigated as a potential treatment for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). While the evidence for its efficacy in these conditions is limited, Cerebroprotein's neurotrophic properties may offer neuroprotective benefits and support neuronal function in neurodegenerative disorders.
Cerebroprotein for Injection is typically administered intravenously or intramuscularly under medical supervision. The dosage and duration of treatment depend on the specific indication, the patient's clinical status, and the healthcare provider's recommendations.
Treatment with Cerebroprotein may involve an initial loading dose followed by maintenance doses administered at regular intervals. The treatment regimen may vary based on the severity of the neurological condition and the patient's response to therapy.
Precautions:
Cerebroprotein is generally well-tolerated, but adverse effects such as fever, headache, nausea, and injection site reactions may occur in some patients. These side effects are usually mild and transient.
Patients with a history of hypersensitivity reactions to porcine-derived products should use Cerebroprotein with caution and may require careful monitoring for signs of allergic reactions.
){kind=link}